Commentary
Open Access
Commentary on Phosphodiesterase 5 Inhibitor Mirodenafil Ameliorates Alzheimer-Like Pathology and Symptoms by Multimodal Actions
David R. Greeley, MD, FAAN
DOI: 10.53043/2320-1991.acb90032
PDF
